Impact BioMedical Statistics

Total Valuation

IBO has a market cap or net worth of $47.92 million. The enterprise value is $70.79 million.

Market Cap	47.92M
Enterprise Value	70.79M

Important Dates

The last earnings date was Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

IBO has 104.62 million shares outstanding. The number of shares has decreased by -80.23% in one year.

Current Share Class	104.62M
Shares Outstanding	104.62M
Shares Change (YoY)	-80.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.09%
Owned by Institutions (%)	0.51%
Float	104.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	219.66
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,831.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.04

Current Ratio	0.04
Quick Ratio	0.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.75

Financial Efficiency

Return on equity (ROE) is -346.99% and return on invested capital (ROIC) is -8.84%.

Return on Equity (ROE)	-346.99%
Return on Assets (ROA)	-7.68%
Return on Invested Capital (ROIC)	-8.84%
Return on Capital Employed (ROCE)	71.39%
Revenue Per Employee	$12,500
Profits Per Employee	-$22.10M
Employee Count	2
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, IBO has paid $33,000 in taxes.

Income Tax	33,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-80.84%
50-Day Moving Average	0.55
200-Day Moving Average	0.72
Relative Strength Index (RSI)	41.59
Average Volume (20 Days)	86,096

Short Selling Information

The latest short interest is 151,978, so 0.15% of the outstanding shares have been sold short.

Short Interest	151,978
Short Previous Month	150,776
Short % of Shares Out	0.15%
Short % of Float	0.15%
Short Ratio (days to cover)	1.41

Income Statement

In the last 12 months, IBO had revenue of $25,000 and -$44.19 million in losses. Loss per share was -$3.69.

Revenue	25,000
Gross Profit	23,000
Operating Income	-3.99M
Pretax Income	-44.21M
Net Income	-44.19M
EBITDA	-3.13M
EBIT	-3.99M
Loss Per Share	-$3.69

Full Income Statement

Balance Sheet

The company has $12,000 in cash and $22.88 million in debt, giving a net cash position of -$22.87 million or -$0.22 per share.

Cash & Cash Equivalents	12,000
Total Debt	22.88M
Net Cash	-22.87M
Net Cash Per Share	-$0.22
Equity (Book Value)	-8.85M
Book Value Per Share	-0.97
Working Capital	-22.88M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.04M
Capital Expenditures	n/a
Free Cash Flow	-4.04M
FCF Per Share	-$0.04

Full Cash Flow Statement

Margins

Gross Margin	92.00%
Operating Margin	-15,948.00%
Pretax Margin	-176,820.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	80.23%
Shareholder Yield	80.23%
Earnings Yield	-92.22%
FCF Yield	-8.43%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IBO has an Altman Z-Score of -6.12 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.12
Piotroski F-Score	1